Growth Metrics

Day One Biopharmaceuticals (DAWN) Other Working Capital Changes (2022 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Other Working Capital Changes for 4 consecutive years, with -$3.7 million as the latest value for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 173.22% year-over-year to -$3.7 million; the TTM value through Dec 2025 reached -$2.5 million, down 139.72%, while the annual FY2025 figure was -$2.5 million, 151.83% down from the prior year.
  • Other Working Capital Changes was -$3.7 million for Q4 2025 at Day One Biopharmaceuticals, down from $796000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $5.1 million in Q4 2024, with the low at -$3.7 million in Q4 2025.
  • Historically, Other Working Capital Changes has averaged $251000.0 across 4 years, with a median of $91000.0 in 2025.
  • Biggest YoY gain for Other Working Capital Changes was 2179.1% in 2023; the steepest drop was 2247.06% in 2023.
  • Over 4 years, Other Working Capital Changes stood at $184000.0 in 2022, then surged by 62.5% to $299000.0 in 2023, then surged by 1593.65% to $5.1 million in 2024, then crashed by 173.22% to -$3.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were -$3.7 million in Q4 2025, $796000.0 in Q3 2025, and $340000.0 in Q2 2025.